Off-market Deal: Mid-Atlantic Medical Services Business ($1-2M EBITDA)

Project Spectrum: Qualified users may request additional information via the PEmarket listing.

‍Project Spectrum: Blinded Company Snapshot

• Transaction type: Acquisition of a Privately Held Operating Company
• Listing type: Off-market (Buy-side Mandate)
• Location: Mid-Atlantic
• Industry: Medical Practice
• Revenue: $20-22 million
• EBITDA: $1-2 million 

Business Overview
This independent clinical laboratory has more than four decades of experience serving physicians, hospitals, long-term care facilities, pain management clinics, and other healthcare providers. The laboratory offers a broad menu of diagnostic tests, supported by advanced laboratory technologies and a commitment to accurate results, responsive customer service, and regulatory compliance.

Products & Services
The laboratory provides comprehensive clinical testing services, including chemistry, hematology, microbiology, immunology, virology, molecular diagnostics, forensic toxicology, therapeutic drug monitoring, and STAT testing. Its broad testing capabilities enable healthcare providers to support disease diagnosis, treatment monitoring, and patient care through a single laboratory partner.

Target Customer Base
Primary customers include physician practices, hospitals, nursing homes, pain management clinics, behavioral health providers, drug testing facilities, and other healthcare organizations requiring reliable diagnostic laboratory services and fast reporting.

Industry Market
The clinical laboratory services industry is supported by growing demand for diagnostic testing driven by an aging population, increased prevalence of chronic diseases, advances in molecular diagnostics, and expanding use of laboratory testing in preventive and personalized healthcare. Independent laboratories continue to play an important role by providing specialized testing and rapid turnaround for healthcare providers.

Market Geography
Operating across multiple U.S. states, the laboratory serves a broad healthcare market with demand driven by large patient populations, expanding outpatient care, and increasing utilization of diagnostic testing. Continued growth in molecular diagnostics and preventive healthcare creates ongoing opportunities for independent laboratory providers.

Next Steps:

View the listing on PEmarket.com to request more information or Sign up for PEmarket to access additional lower middle market M&A opportunities.

Background Information & Disclaimers: PEmarket is a marketplace for lower middle market acquisition opportunities. We connect qualified acquirers, including strategic buyers, private equity firms, family offices, independent sponsors, and other acquisition professionals, directly with the buy-side and sell-side advisors representing listed opportunities. The information presented is a high-level summary provided solely for informational purposes. It does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product, and it is not intended as investment, legal, tax, or financial advice. This opportunity concerns a potential control-change acquisition of a privately held business. Additional information may be made available to qualified acquirers and other approved parties subject to the requirements of the seller, buyer, or their representative. Certain opportunities may require execution of confidentiality agreements, satisfaction of transaction-specific qualification criteria, and/or additional screening prior to the release of detailed information.

‍